DrugPatentWatch Database Preview

QUARTETTE Drug Profile

  Purchase this report

or, see our see our flat-rate plans

« Back to Dashboard

When do Quartette patents expire, and when can generic versions of Quartette launch?

Quartette is a drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.

This drug has twenty-four patent family members in thirteen countries.

The generic ingredient in QUARTETTE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.

Summary for QUARTETTE

International Patents:	24
US Patents:	2
Applicants:	1
NDAs:	1
Suppliers / Packagers:	3
Bulk Api Vendors:	3
Formulation / Manufacturing:	see details
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for QUARTETTE
DailyMed Link:	QUARTETTE at DailyMed

US Patents and Regulatory Information for QUARTETTE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Teva Branded Pharm	QUARTETTE	ethinyl estradiol; levonorgestrel	TABLET;ORAL	204061-001	Mar 28, 2013	AB	RX	Yes	Yes
Teva Branded Pharm	QUARTETTE	ethinyl estradiol; levonorgestrel	TABLET;ORAL	204061-001	Mar 28, 2013	AB	RX	Yes	Yes			Y

  Purchase this report

or, see our see our flat-rate plans

Paragraph IV (Patent) Challenges for QUARTETTE

Drugname	Dosage	Strength	RLD	Submissiondate
	Tablets	0.15 mg/0.02 mg, 0.15 mg/0.025 mg, 0.15 mg/0.03 mg and 0.01 mg		2013-07-10

  Purchase this report

or, see our see our flat-rate plans

International Patents for QUARTETTE

Country	Document Number	Estimated Expiration
Russian Federation	2009120528
Canada	2668211
Argentina	051931
Israel	198441

Supplementary Protection Certificates for QUARTETTE

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C0001	France		PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
1214076/01	Switzerland		PRODUCT NAME: DROSPIRENONE + ETHINYLESTRADIOL; REGISTRATION NUMBER/DATE: SWISSMEDIC 57946 13.06.2008
00C/027	Belgium		PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
2006 00038	Denmark		PRODUCT NAME: ETHINYLESTRADIOL (SOM BETA-CYCLODEXTRIN-CLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 38687 20060627; FIRST REG. NO/DATE: EU RVG 31781 20050804